The new analysis showed that short-term and long-term costs of treatment for prostate cancer vary widely based on which treatment strategy for persons initially received. Merrimack Pharmaceuticals, Inc, and sanofi-aventis announced that the first patient received a starting dose in phase 2, randomized, double-blind clinical study combining MM-121 with exemestane (Aromasin ®) in patients with breast cancer. ATLANTA - March levaquin and corticosteroids 16, 2010 (cancerfacts. com) - one of the least discussed aspects of the present discussion, the actual cost of health care treatment, and few studies ever to include cost considerations benefit from these treatments. NEW YORK - March 11, 2010 (cancerfacts. com) - a company Pfizer Inc announced today that the suspension of large clinical trials of its lung cancer drug. PHILADELPHIA - March 9, 2010 - Patients with obesity and colon cancer have a higher risk of death or recurrent disease compared with those who are within the normal weight range, according to a report in the
Clinical Cancer Research. LONDON - March 8, 2010 - Anglo-Swedish pharmaceutical company AstraZeneca, said Monday that its colorectal cancer drug failed to show that it is better than drug competitor. Hangzhou, China - March 8, 2010 (cancerfacts. COM) - Two proteins present in the blood of people with colon cancer can serve as markers accurately predict whether the disease will spread, say researchers in China. Seattle - March 2, 2010 (cancerfacts. com) - Women who take certain types of drugs used to prevent and treat osteoporosis may be at lower risk of breast cancer, according to new research.
No comments:
Post a Comment